The investments, which cover through the end of 2023, reflect the
His Catalyst4 nonprofit owned a 52.5% controlling stake in MapLight Therapeutics, which it valued at $120 million at ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.